Clinical trial
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
NCT06507657 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
- Lead sponsor
- University of Minnesota
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 12, 2024
- Completion date
- January 15, 2029
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.